AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUN 3 - (NewsRx.com & NewsRx.net) -- Aricept (donepezil hydrochloride), used for the treatment of Alzheimer disease, has shown continued benefits for at least 12 months for stroke survivors experiencing the deterioration of thinking abilities caused by stroke or multiple strokes, also called vascular dementia (VaD), according to one recent study.
Researchers reported at the American Psychiatric Association meeting the results of a study using Aricept with 453 patients diagnosed with VaD.
The study was designed to determine if the drug was safe and effective long-term (1 year) and could help maintain or improve the memory loss and cognitive function that can be caused by VaD.
The results indicated that patients receiving Aricept sustained their cognitive function, which was measured by their Alzheimer Disease Assessment Scale cognitive scores.
National Stroke Association is optimistic about the findings and hopes further research will show the same promising results.
"The finding of sustained memory benefit for stroke survivors at 12 months with the drug Precept ...
Source: HighBeam Research, Alzheimer disease treatment effective in stroke survivors with...